A new trading day began on Friday, with Cidara Therapeutics Inc (NASDAQ: CDTX) stock price up 105.41% from the previous day of trading, before settling in for the closing price of $105.99. CDTX’s price has ranged from $13.82 to $121.21 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.30%. Meanwhile, its annual earnings per share averaged 71.87%. With a float of $23.89 million, this company’s outstanding shares have now reached $29.34 million.
Cidara Therapeutics Inc (CDTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cidara Therapeutics Inc is 24.02%, while institutional ownership is 85.42%. The most recent insider transaction that took place on Sep 11 ’25, was worth 29,797. In this transaction Chief Medical Officer of this company sold 474 shares at a rate of $62.86, taking the stock ownership to the 31,418 shares. Before that another transaction happened on Jun 26 ’25, when Company’s Director bought 2,272,727 for $44.00, making the entire transaction worth $99,999,988. This insider now owns 3,365,523 shares in total.
Cidara Therapeutics Inc (CDTX) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -5.38 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.28% during the next five years compared to 1.30% growth over the previous five years of trading.
Cidara Therapeutics Inc (NASDAQ: CDTX) Trading Performance Indicators
Here are Cidara Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.78, a number that is poised to hit -1.62 in the next quarter and is forecasted to reach -6.44 in one year’s time.
Technical Analysis of Cidara Therapeutics Inc (CDTX)
Looking closely at Cidara Therapeutics Inc (NASDAQ: CDTX), its last 5-days average volume was 4.0 million, which is a jump from its year-to-date volume of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 77.02%.
During the past 100 days, Cidara Therapeutics Inc’s (CDTX) raw stochastic average was set at 99.35%, which indicates a significant increase from 99.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 6.00 in the past 14 days, which was higher than the 4.90 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $95.60, while its 200-day Moving Average is $50.04. However, in the short run, Cidara Therapeutics Inc’s stock first resistance to watch stands at $218.77. Second resistance stands at $219.84. The third major resistance level sits at $220.82. If the price goes on to break the first support level at $216.72, it is likely to go to the next support level at $215.74. Should the price break the second support level, the third support level stands at $214.67.
Cidara Therapeutics Inc (NASDAQ: CDTX) Key Stats
With a market capitalization of 6.84 billion, the company has a total of 31,439K Shares Outstanding. Currently, annual sales are 1,280 K while annual income is -169,830 K. The company’s previous quarter sales were 0 K while its latest quarter income was -83,230 K.
